Literature DB >> 20682760

Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste.

Aneta Aleksova1, Marco Merlo, Massimo Zecchin, Gastone Sabbadini, Giulia Barbati, Giancarlo Vitrella, Andrea Di Lenarda, Gianfranco Sinagra.   

Abstract

OBJECTIVE: There is a paucity and inconsistency of data regarding the natural history of patients affected by idiopathic dilated cardiomyopathy (IDCM) and atrial fibrillation (AF). We examined the prognostic implications of AF in a subset of patients with IDCM.
METHODS: We analyzed the data of 539 patients with IDCM enrolled in the Heart Muscle Disease Registry of Trieste.
RESULTS: At baseline, 52 (9.6%) of 539 patients had AF. There was no difference in survival of patients with either AF or sinus rhythm at enrollment (P = .28). During long-term follow-up (90 ± 58 months), AF was detected on ECG/ECG-Holter monitoring in 28 (5.7%) of 487 patients in sinus rhythm at baseline. Predictors of new onset of AF at multivariate analysis were a more dilated left atrium (OR 1.35, 95% CI 1.06-1.72; P = .01) and a lower left ventricle ejection fraction (for 10% decrease, OR 2.41, 95% CI 1.24-4.69, P = .016). Patients developing AF had higher mortality/heart transplantation rate compared to patients who maintained sinus rhythm during follow-up (P < .001). At multivariate analysis, new onset AF (HR 3.67, 95% CI 2.07-6.5; P < .001) in the first three years after diagnosis, but not baseline AF, was found to be independently associated with a worse outcome.
CONCLUSIONS: Atrial fibrillation is relatively frequent in patients with IDCM. The early development of AF during follow-up, but not its presence at baseline, is associated with poor survival.

Entities:  

Mesh:

Year:  2010        PMID: 20682760      PMCID: PMC3006600          DOI: 10.3121/cmr.2010.908

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  37 in total

1.  Congestive heart failure: fifty years of progress.

Authors:  E Braunwald; M R Bristow
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

2.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

Review 3.  Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle.

Authors:  Yong-Mei Cha; Margaret M Redfield; Win-Kuang Shen; Bernard J Gersh
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

Review 4.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

Authors:  William H Maisel; Lynne Warner Stevenson
Journal:  Am J Cardiol       Date:  2003-03-20       Impact factor: 2.778

5.  Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability.

Authors:  Yong-Mei Cha; Petras P Dzeja; Win K Shen; Arshad Jahangir; Chari Y T Hart; Andre Terzic; Margaret M Redfield
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04       Impact factor: 4.733

6.  Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.

Authors:  H J Crijns; G Tjeerdsma; P J de Kam; F Boomsma; I C van Gelder; M P van den Berg; D J van Veldhuisen
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

7.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors:  S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

8.  Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs.

Authors:  Kaori Shinagawa; Yan-Fen Shi; Jean-Claude Tardif; Tack-Ki Leung; Stanley Nattel
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

9.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

10.  [Prognosis of primary non-obstructive cardiomyopathies].

Authors:  G Convert; J Delaye; J Beaune; A Biron; A Gonin
Journal:  Arch Mal Coeur Vaiss       Date:  1980
View more
  5 in total

1.  Evolution of electrocardiographic abnormalities in association with neuromuscular disorders and survival in left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Daniel Gerger; Peter Jirak; Christian Wegner; Josef Finsterer
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-06-16       Impact factor: 1.468

Review 2.  Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives.

Authors:  M Merlo; T Caiffa; M Gobbo; L Adamo; G Sinagra
Journal:  Int J Cardiol Heart Vasc       Date:  2018-03-08

3.  Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data.

Authors:  Benjamin J R Buckley; Stephanie L Harrison; Dhiraj Gupta; Elnara Fazio-Eynullayeva; Paula Underhill; Gregory Y H Lip
Journal:  J Am Heart Assoc       Date:  2021-11-15       Impact factor: 5.501

Review 4.  Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments.

Authors:  Nicoletta Orphanou; Efstathios Papatheodorou; Aris Anastasakis
Journal:  Heart Fail Rev       Date:  2021-07-14       Impact factor: 4.654

5.  Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy-tailored prognostic model.

Authors:  Ewa Dziewięcka; Matylda Gliniak; Mateusz Winiarczyk; Arman Karapetyan; Sylwia Wiśniowska-Śmiałek; Aleksandra Karabinowska; Marcin Dziewięcki; Piotr Podolec; Paweł Rubiś
Journal:  ESC Heart Fail       Date:  2020-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.